Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Non-Current Debt (2016 - 2022)

Avanos Medical's Non-Current Debt history spans 8 years, with the latest figure at $226.3 million for Q4 2022.

  • On a quarterly basis, Non-Current Debt rose 74.08% to $226.3 million in Q4 2022 year-over-year; TTM through Dec 2022 was $226.3 million, a 74.08% increase, with the full-year FY2022 number at $226.3 million, up 74.08% from a year prior.
  • Non-Current Debt hit $226.3 million in Q4 2022 for Avanos Medical, up from $130.0 million in the prior quarter.
  • Over the last five years, Non-Current Debt for AVNS hit a ceiling of $542.0 million in Q1 2018 and a floor of $130.0 million in Q4 2021.
  • Historically, Non-Current Debt has averaged $269.9 million across 4 years, with a median of $247.6 million in 2018.
  • Biggest five-year swings in Non-Current Debt: tumbled 57.34% in 2018 and later surged 74.08% in 2022.
  • Tracing AVNS's Non-Current Debt over 4 years: stood at $247.7 million in 2018, then increased by 0.16% to $248.1 million in 2019, then tumbled by 47.6% to $130.0 million in 2021, then surged by 74.08% to $226.3 million in 2022.
  • Business Quant data shows Non-Current Debt for AVNS at $226.3 million in Q4 2022, $130.0 million in Q4 2021, and $248.1 million in Q4 2019.